SCIENTIFIC
PROGRAMME
SESSION I
SMOLDERING
MYELOMA
SESSION II
DIAGNOSIS OF
MULTIPLE MYELOMA
SESSION III
FRONTLINE THERAPY
IN PATIENTS NOT
ELIGIBLE FOR
AUTOLOGOUS
STEM CELL
TRANSPLANTATION
SESSION IV
FRONTLINE THERAPY
IN PATIENTS
ELIGIBLE FOR
AUTOLOGOUS
STEM CELL
TRANSPLANTATION
SESSION V
MRD AND THE
MICROENVIRONMENT
SESSION VI
RELAPSED MULTIPLE
MYELOMA
SESSION VII
THE FUTURE :
RECENT CLINICAL
TRIALS IN RELAPSE
SESSION VIII
DATA MANAGEMENT
ISSUES
SESSION IX
PLASMA CELL
DISORDERS
SELECTED
ABSTRACTS FOR AN
ORAL PRESENTATION
ABSTRACTS
SELECTED AS
POSTERS
DISCLOSURES
